Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Trastuzumab emtansine

Copy Product Info
😃Good
Catalog No. T36647Cas No. 1018448-65-1
Alias Trastuzumab emtansine, T-DM1

Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody–drug conjugate that combines the HER2-targeted antitumor specificity of trastuzumab with the potent cytotoxic activity of the microtubule inhibitor DM1, Trastuzumab emtansine enables selective intracellular delivery of the cytotoxic payload to HER2-expressing cells and supporting translational and mechanistic research in advanced breast cancer models.

Trastuzumab emtansine

Trastuzumab emtansine

Copy Product Info
😃Good
Purity: 98%
Catalog No. T36647Alias Trastuzumab emtansine, T-DM1Cas No. 1018448-65-1
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody–drug conjugate that combines the HER2-targeted antitumor specificity of trastuzumab with the potent cytotoxic activity of the microtubule inhibitor DM1, Trastuzumab emtansine enables selective intracellular delivery of the cytotoxic payload to HER2-expressing cells and supporting translational and mechanistic research in advanced breast cancer models.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$597-In Stock
5 mg$1,320-In Stock
10 mg$2,150-In Stock
25 mg$3,190-In Stock
50 mg$4,280-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98%
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody–drug conjugate that combines the HER2-targeted antitumor specificity of trastuzumab with the potent cytotoxic activity of the microtubule inhibitor DM1, Trastuzumab emtansine enables selective intracellular delivery of the cytotoxic payload to HER2-expressing cells and supporting translational and mechanistic research in advanced breast cancer models.
In vitro
Trastuzumab emtansine (2 μg/mL; 3 d) markedly inhibits the proliferation of epithelial ovarian cancer (EOC) cells[2].
In vivo
Method: Trastuzumab emtansine was administered intravenously at 15 mg/kg three to five times weekly for 3 weeks in CB-17/SCID mice injected with OVA10 cells.
Result: Trastuzumab emtansine produced significant antitumor effects in tumor-bearing mice[2].
SynonymsTrastuzumab emtansine, T-DM1
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Antigen Details
Uniprot ID
TargetHER2
Chemical Properties
FormulaN/A
Cas No.1018448-65-1
Smiles[Trastuzumab emtansine]
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storagekeep away from moisture,keep away from direct sunlight,store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 160 mg/mL, Sonication is recommended.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Keywords

Related Tags: buy Trastuzumab emtansine | purchase Trastuzumab emtansine | Trastuzumab emtansine cost | order Trastuzumab emtansine | Trastuzumab emtansine chemical structure | Trastuzumab emtansine in vivo | Trastuzumab emtansine in vitro | Trastuzumab emtansine formula